Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
The paper by Jagsi in Cancer is possibly an example of classical
confounding. The industry-funded trials may differ from non-industry
funded trials in a way (e.g the treatments used) that is associated with
the outcome. The treatments they compare are actually more effective.
The authors themselves note this, though not very clearly. Industry
funded trials may not distort results at all (which is not the impression
left in the reader's mind after reading the BMJ), but they address
different questions.
They may choose to investigate areas of cancer where success is
likely to be greater. The questions they address and the designs of the
studies may be different. This is bias, but of a very different nature to
the idea that they distort results. The evidence is they tend to interpret
similar results with a more positive spin, but the results themselves are
not distorted.
Had Jagsi et al compared like with like in terms of the types of
trials they may (or may not) have found similar results. The paper in
Cancer has not answered the correct question.
Confounded conflicts
The paper by Jagsi in Cancer is possibly an example of classical
confounding. The industry-funded trials may differ from non-industry
funded trials in a way (e.g the treatments used) that is associated with
the outcome. The treatments they compare are actually more effective.
The authors themselves note this, though not very clearly. Industry
funded trials may not distort results at all (which is not the impression
left in the reader's mind after reading the BMJ), but they address
different questions.
They may choose to investigate areas of cancer where success is
likely to be greater. The questions they address and the designs of the
studies may be different. This is bias, but of a very different nature to
the idea that they distort results. The evidence is they tend to interpret
similar results with a more positive spin, but the results themselves are
not distorted.
Had Jagsi et al compared like with like in terms of the types of
trials they may (or may not) have found similar results. The paper in
Cancer has not answered the correct question.
Competing interests:
None declared
Competing interests: No competing interests